Herbal Monograph
Skullcap
Scutellaria lateriflora L.
Lamiaceae (Labiatae)
Premier nervine tonic that restores depleted nerves while calming anxiety and...
Overview
Plant Description
Herbaceous perennial, 20-80 cm tall, with slender, erect to ascending, branched, square (four-angled) stems characteristic of the Lamiaceae family. Stems are glabrous to finely pubescent, often tinged purple. Leaves opposite, ovate to lanceolate-ovate, 3-8 cm long and 1.5-4 cm wide, with coarsely serrate to crenate-serrate margins; leaf base rounded to subcordate; petioles 0.5-2 cm long; upper leaves becoming smaller and more sessile. Flowers small (6-8 mm long), tubular, bilabiate (two-lipped), blue to violet (occasionally pink or white), borne in one-sided axillary and terminal racemes (the lateral raceme arrangement giving the species its epithet 'lateriflora'). Calyx with a characteristic crest or shield-shaped protuberance (scutellum) on the upper lip — the distinctive feature of the genus Scutellaria and the origin of the common name 'skullcap.' Fruit consists of 4 small, warty nutlets enclosed within the persistent calyx. Rhizome slender, fibrous, creeping, producing new stems annually. The plant spreads both by seed and by rhizome extension.
Habitat
Moist to wet habitats, including stream banks, marshes, wet meadows, swamp margins, moist woodlands, floodplains, lakeshores, and damp thickets. Prefers partial shade to full sun. Thrives in rich, moist, humus-rich soil. Tolerates some standing water. Commonly found in alluvial soils along watercourses. USDA Hardiness Zones 3-8. Often grows in association with other moisture-loving species such as Impatiens spp. (jewelweed), Symphyotrichum spp. (asters), and various Carex spp. (sedges).
Distribution
Native to North America, ranging from Newfoundland and Quebec south to Florida, west to British Columbia, Oregon, and New Mexico. Found throughout the eastern and central United States and across southern Canada. Most abundant in the northeastern and midwestern United States. Also reported from scattered populations in the Pacific Northwest. Not native to Europe, Asia, or the Southern Hemisphere, though it has been introduced and cultivated in Europe for medicinal purposes. Commercial cultivation occurs primarily in the United States, with some production in Europe.
Parts Used
Aerial parts (Scutellariae lateriflorae herba — leaves, stems, and flowers)
Preferred: Dried aerial parts for infusions; fresh plant tincture (widely considered superior by practitioners); dried herb tincture; encapsulated dried herb or standardized extract
The aerial parts harvested during flowering constitute the medicinal material. The American Herbal Pharmacopoeia (AHP) monograph (2009) specifies the aerial parts of S. lateriflora as the official drug. Unlike S. baicalensis where the root is used, only the above-ground parts of S. lateriflora are employed medicinally. The British Herbal Pharmacopoeia (BHP 1983) includes a monograph for Scutellaria lateriflora herba. AHPA Botanical Safety Handbook (2nd edition) classifies the aerial parts as Safety Class 1 (can be safely consumed when used appropriately). Quality material should contain detectable levels of baicalin and other characteristic Scutellaria flavonoids; absence may indicate adulteration.
Key Constituents
Flavonoids (flavones and flavone glycosides)
Flavonoids are the principal class of bioactive compounds in S. lateriflora and are responsible for the nervine and anxiolytic activity. The GABA-A receptor modulatory activity of baicalein, wogonin, and chrysin — acting at or near the benzodiazepine binding site — provides a well-characterized molecular basis for the traditional anxiolytic and nervine tonic uses. The flavonoid profile also underpins the anti-inflammatory and antioxidant properties. Awad et al. (2003) identified the major flavonoids in S. lateriflora, and subsequent in vitro studies have confirmed GABA-A receptor affinity. The flavonoid glycosides (baicalin, scutellarin) are metabolized by intestinal bacteria to their aglycone forms (baicalein, scutellarein), which have superior bioavailability and receptor affinity. The combined activity of multiple flavonoids acting through complementary mechanisms (GABA-A modulation, antioxidant, anti-inflammatory) likely accounts for the broad nervine-tonic properties of the whole herb.
Iridoids
Iridoids represent a secondary class of bioactive constituents in S. lateriflora. Catalpol and related iridoids have demonstrated neuroprotective properties in animal models, which may contribute to the traditional nervine tonic reputation of skullcap — i.e., the ability to not merely sedate but to nourish and restore nervous system function over time. However, the clinical significance of the iridoid fraction in S. lateriflora preparations has not been independently established.
Volatile oil (essential oil)
The essential oil fraction is minor in S. lateriflora and contributes modestly to overall effects. Individual terpene components (e.g., beta-caryophyllene, an endocannabinoid CB2 receptor agonist) may contribute marginally to the nervine and anti-inflammatory profile, but the flavonoid fraction is the dominant bioactive class.
Tannins
Tannins contribute to the mildly astringent properties of skullcap and may have some role in wound healing and anti-inflammatory effects. Their primary relevance is organoleptic (contributing to the slightly bitter and astringent taste) rather than being central to the nervine action.
Other constituents
Minor constituent classes contributing to the overall nutritive and antioxidant profile of the herb. Not considered primary active compounds for the nervine indications.
Herbal Actions
The defining action of S. lateriflora in the Western herbal tradition. Skullcap is classified as a trophorestorative nervine tonic — an herb that nourishes and restores the functional integrity of the nervous system over time, particularly when depleted by chronic stress, overwork, or illness. Distinguished from a simple sedative by its capacity to rebuild nervous system resilience with sustained use, rather than merely suppressing nervous excitability in the short term. Hoffmann (2003) classifies skullcap as a premier nervine tonic. The Eclectic physicians described it as the 'best nervine' in the materia medica for nervous exhaustion (Felter and Lloyd, 1898). This tonic action is best realized with consistent use over weeks to months.
[1, 6, 7, 8]In addition to its tonic properties, skullcap acts as a nervine relaxant, reducing nervous tension and excitability. This dual action (tonic + relaxant) is relatively uncommon and highly valued — it calms nervous excess while simultaneously nourishing the depleted nervous system. The relaxant action is gentle and does not typically produce significant sedation or cognitive impairment at standard doses. Wolfson and Hoffmann (2003) RCT in 43 healthy volunteers demonstrated significant reduction in anxiety using a proprietary S. lateriflora preparation compared to placebo, confirming the acute anxiolytic-relaxant effect.
[4, 6, 7]Relieves smooth muscle spasm
Relaxes skeletal and smooth muscle spasm, particularly when spasm is driven by nervous tension or stress. The antispasmodic action complements the nervine relaxant effect, addressing the somatic manifestations of anxiety and nervous tension — muscle tightness, tension headaches, menstrual cramps of nervous origin. The Eclectic physicians specifically valued skullcap for chorea, tremors, and nervous twitching. This action is attributed in part to the GABA-A modulatory activity of the flavonoid constituents.
[2, 6, 8]Skullcap has a distinct bitter taste, reflecting its flavonoid content. The bitter quality stimulates digestive secretions and promotes appetite and digestive function. This mild bitter tonic action is secondary to the nervine effects but contributes to its utility in conditions where nervous tension impairs digestive function (nervous dyspepsia, stress-related appetite loss).
[6]Historical use for convulsive conditions (epilepsy, tetanus, chorea) dates to the Eclectic and Physiomedicalist traditions. Modern preclinical research supports anticonvulsant potential: baicalein and baicalin have demonstrated anticonvulsant activity in animal models of chemically induced seizures, likely mediated through GABA-A receptor modulation. Clinical evidence for anticonvulsant use in humans is absent, and skullcap should not be used as a substitute for conventional anticonvulsant therapy. However, it may have an adjunctive role in supporting nervous system stability.
[6, 8, 11]At higher doses or in sensitive individuals, skullcap can promote sleep onset and improve sleep quality, though the sedative effect is milder than that of valerian (Valeriana officinalis) or hops (Humulus lupulus). The sedative action is dose-dependent and secondary to the primary nervine tonic and relaxant actions. Often combined with stronger sedative herbs (valerian, passionflower, hops) in sleep formulas, where skullcap contributes its calming nervine quality without heavy sedation.
[6, 7]Therapeutic Indications
Nervous System
Anxiety, nervous tension, and stress
The primary indication for skullcap. Wolfson and Hoffmann (2003) conducted a double-blind, placebo-controlled crossover study in 43 healthy volunteers using a proprietary S. lateriflora preparation; the active treatment produced significant anxiolytic effects compared to placebo using a visual analogue scale for anxiety. The onset of effect was noted within 30 minutes. The British Herbal Pharmacopoeia (1983) lists nervous states, including anxiety, as an indication. The American Herbal Pharmacopoeia monograph (2009) supports the anxiolytic indication. Skullcap is particularly suited to anxiety characterized by nervous exhaustion, circular worry, muscular tension, and irritability.
[1, 2, 4, 6]Nervous exhaustion and neurasthenia
The nervine tonic action — nourishing and restoring a depleted nervous system — is considered the most distinctive therapeutic property of skullcap in the Western herbal tradition. Indicated for chronic stress, burnout, overwork, prolonged emotional strain, and the state the Eclectics termed 'neurasthenia' or 'nervous debility.' The Eclectic physicians considered skullcap the principal remedy for nervous exhaustion arising from mental overwork (Felter and Lloyd, 1898; Ellingwood, 1919). Best used consistently over 2-8 weeks for this indication. Often combined with Avena sativa (milky oats), Withania somnifera (ashwagandha), or Verbena officinalis (vervain) for nervous exhaustion.
[6, 7, 8, 9]Insomnia, particularly from nervous tension or an overactive mind
Traditional use as a sleep-supportive herb, particularly when insomnia is driven by an inability to release mental tension, racing thoughts, or worry at bedtime. The sedative action is mild relative to valerian or hops, making skullcap most effective for mild sleep difficulties or as a component in compound sleep formulas. The Eclectic physicians valued it for 'sleeplessness caused by nervous excitement, pain, or worry' (Felter and Lloyd, 1898). Commonly combined with Valeriana officinalis (valerian), Passiflora incarnata (passionflower), or Humulus lupulus (hops) in sleep formulations.
[2, 6, 8]Nervous headache and tension headache
Traditional indication for headaches arising from nervous tension, stress, or muscular contraction in the neck and scalp. The combined nervine relaxant and antispasmodic actions address both the central nervous system component (nervous excitability) and the peripheral component (muscular tension). Felter and Lloyd (1898) specifically list 'nervous headache' among the Eclectic indications. Often combined with Lavandula angustifolia (lavender) or Matricaria recutita (chamomile) for tension headaches.
[6, 8]Seizure disorders and convulsive conditions (historical/adjunctive use only)
Historical use for epilepsy, chorea (St. Vitus' dance), and tremors in both the Eclectic and Physiomedicalist traditions. The common name 'mad-dog skullcap' derives from its historical use for rabies-associated convulsions (an indication no longer relevant). Preclinical studies demonstrate anticonvulsant effects of baicalein and baicalin in animal seizure models. However, there are no human clinical trials for epilepsy, and skullcap must NOT be used as a substitute for conventional anticonvulsant medications. May have a potential adjunctive role in supporting nervous system stability alongside conventional treatment, under medical supervision only.
[8, 9, 11]Musculoskeletal System
Muscle tension, spasm, and tremor associated with nervous tension
The antispasmodic and nervine relaxant actions combine to address musculoskeletal tension driven by stress and nervous excitability. Traditionally used for stress-related muscular holding patterns, nervous twitching, restless legs, and tremors. The Eclectic physicians valued skullcap specifically for chorea (involuntary movements) and muscular twitching (Felter and Lloyd, 1898). Often combined with Valeriana officinalis (valerian) or Actaea racemosa (black cohosh) for musculoskeletal tension formulas.
[2, 6, 8]Digestive System
Nervous dyspepsia and stress-related digestive complaints
The combination of nervine relaxant, antispasmodic, and mild bitter tonic actions makes skullcap appropriate for digestive complaints driven by nervous tension — nervous stomach, stress-related loss of appetite, and functional digestive disturbance with a strong psychological component. The bitter quality stimulates digestive secretions. Traditionally combined with Matricaria recutita (chamomile), Melissa officinalis (lemon balm), or Mentha x piperita (peppermint) for nervous digestive complaints.
[6]Reproductive System
Premenstrual nervous tension and irritability
Traditional use for nervous irritability and tension associated with the premenstrual phase. The nervine relaxant and antispasmodic actions address both the emotional and the physical tension components of premenstrual syndrome (PMS). Traditionally combined with Vitex agnus-castus (chaste tree) for hormonal regulation and with Viburnum prunifolium (black haw) or Actaea racemosa (black cohosh) for cramping.
[6, 7]Energetics
Temperature
cool
Moisture
slightly dry
Taste
Tissue States
wind/tension, heat/excitation
In traditional Western herbal energetics, skullcap is classified as cooling and slightly drying. It is specifically indicated for conditions arising from nervous tension (wind/tension tissue state) with heat and excitation of the nervous system. The cooling quality makes it appropriate for individuals who are agitated, irritable, and overwrought — those whose nervous depletion manifests as nervous excitability rather than collapse. The prominent bitter taste reflects the rich flavonoid content and contributes to the grounding, settling quality of the herb. The slight astringency derives from the tannin content. In TCM terms, while S. lateriflora is not a traditional TCM herb (S. baicalensis is), its energetics parallel the clear heat and calm shen categories — it clears heat from the liver and heart, settles the spirit (shen), and relaxes constraint. The related S. baicalensis is classified in TCM as bitter, cold, entering the lung, gallbladder, stomach, and large intestine channels, primarily for clearing heat and drying dampness. Skullcap pairs well with: warming nervines like valerian for balanced formulas; other cooling nervines like passionflower and lemon balm; nutritive tonics like milky oat (Avena sativa) for nervous exhaustion. It is a cooler, more drying nervine than passionflower and more gentle than valerian.
Traditional Uses
Native American medicine
- Cherokee used an infusion of the plant to promote menstruation and for breast pain
- Cherokee used skullcap as a ceremonial herb in certain dances and rituals
- Iroquois used a decoction for diarrhea, heart trouble, and kidney ailments
- Several tribes recognized the plant as a calming and nervine agent
- Used in some traditions for expelling afterbirth
- Root and aerial parts were used for different conditions by different tribes
"Scutellaria lateriflora was known to several Native American peoples of eastern North America. The Cherokee used the plant for ceremonial purposes and as a women's medicine (to promote menses and for breast complaints). The Iroquois employed decoctions for digestive and kidney complaints. While the specific nervine indications that later became central to Western herbal use of skullcap may not have been the primary focus of all Native American uses, the plant's calming properties were recognized. European settlers likely learned of skullcap from indigenous knowledge, and the plant entered American botanical medicine in the late 18th century."
Eclectic medicine (19th-early 20th century American)
- Nervous excitability, restlessness, and inability to sleep
- Nervous exhaustion from overwork, worry, or prolonged illness
- Chorea (St. Vitus' dance) and involuntary muscular movements
- Epilepsy and convulsions (as a nervous sedative)
- Delirium tremens and alcohol withdrawal symptoms
- Neuralgia (nerve pain)
- Nervous headache
- Hysteria (nervous excitability with emotional lability)
- Intermittent fever with nervous symptoms
- Rabies (the historical use that gave the common name 'mad-dog skullcap')
"The Eclectic physicians were the most enthusiastic advocates for Scutellaria lateriflora and considered it among the finest nervines in the materia medica. Felter and Lloyd in King's American Dispensatory (1898) described it as a pure nervine tonic, 'the best remedy for nervous excitability' and nervous exhaustion from overwork. Ellingwood (1919) wrote extensively about its value for nervous irritation, sleeplessness, restlessness, and as a tonic to the nervous system. The Eclectics specifically distinguished skullcap's action as tonic and restorative rather than merely sedative — it was valued for its ability to restore tone to a depleted nervous system. The famous use for 'hydrophobia' (rabies) dates to Dr. Lawrence Van Derveer (1772), who promoted it as a specific remedy for rabies — a claim that was later discredited but which gave the plant its enduring common name 'mad-dog skullcap.' The Physiomedicalist tradition (Cook, 1869) also valued skullcap highly as a nervine tonic and relaxant."
Modern Western herbal medicine (20th-21st century)
- Anxiety and nervous tension (primary modern indication)
- Nervous exhaustion, burnout, and chronic stress
- Insomnia, especially from an overactive mind
- Tension headaches
- Premenstrual nervousness and irritability
- Adjunctive support during benzodiazepine or SSRI tapering (under medical supervision)
- Component of nervine and sleep formulas in combination with valerian, passionflower, hops, or lemon balm
- Support during withdrawal from recreational substances (anxiety and sleep components)
"In contemporary Western herbal practice, skullcap remains one of the most widely used and highly valued nervine tonics. Hoffmann (2003) lists it as a premier nervine tonic and relaxant, indicated for nervous debility, exhaustion, and restless states. Mills and Bone (2000) describe it as particularly suited to conditions of nervous depletion with excitability. The British Herbal Pharmacopoeia (1983) retains the nervine and antispasmodic indications. The American Herbal Pharmacopoeia (2009) published a comprehensive standards of analysis monograph confirming traditional indications and providing quality standards. Modern practitioners particularly value skullcap for its dual tonic-relaxant action, using it both for acute anxiety relief and for long-term nervous system support. It is frequently combined with other herbs in formulas rather than used as a standalone agent."
Modern Research
Anxiolytic effects of Scutellaria lateriflora in healthy volunteers
Randomized, double-blind, placebo-controlled crossover study evaluating three separate single doses (100 mg, 200 mg, 350 mg) of a proprietary freeze-dried S. lateriflora preparation versus placebo on subjective anxiety in 43 healthy volunteers aged 18-65.
Findings: The 350 mg dose produced significant reductions in Total Mood Disturbance and a notable anxiolytic effect compared to placebo on visual analogue scale measures. There was evidence of a dose-response relationship, with the 200 mg dose showing intermediate effects. No significant adverse effects were observed at any dose. The onset of anxiolytic effect was noted within 30 minutes of ingestion.
Limitations: Healthy volunteers, not clinical anxiety patients. Single-dose assessment (not sustained use). Subjective measures only (VAS). Relatively small sample size. Specific freeze-dried preparation may not generalize to all skullcap products.
[4]
Phytochemical analysis and GABA-A receptor activity of Scutellaria lateriflora
Phytochemical investigation of S. lateriflora identifying major flavonoid constituents and evaluating their affinity for the GABA-A benzodiazepine binding site using in vitro receptor binding assays.
Findings: Identified baicalin, baicalein, lateriflorin, dihydrobaicalin, ikonnikoside I, and oroxylin A as key flavonoids in S. lateriflora. Several of these flavonoids demonstrated affinity for the GABA-A benzodiazepine binding site. Baicalein showed particularly strong binding. The study provided a phytochemical basis for the traditional anxiolytic and nervine uses of S. lateriflora.
Limitations: In vitro study only; receptor binding affinity does not directly predict clinical efficacy. Does not account for bioavailability, metabolism, or blood-brain barrier penetration in vivo. Single plant source analyzed.
[11]
Survey of skullcap users: self-reported effects and safety
A structured online survey of American skullcap (S. lateriflora) users conducted as part of the American Herbal Pharmacopoeia monograph project, collecting self-reported data on reasons for use, perceived effects, dosage patterns, and adverse experiences.
Findings: Respondents reported using skullcap primarily for anxiety, insomnia, and nervous tension. The majority reported beneficial effects. Common preparation methods included tincture (most frequently cited), infusion/tea, and capsules. Fresh plant tincture was frequently considered more effective than dried plant preparations by users and practitioners. Few adverse effects were reported, and those mentioned were generally mild (drowsiness, digestive upset). The survey data supported the traditional indications and generally favorable safety profile.
Limitations: Self-reported data subject to recall and selection bias. No control group. Respondents were predominantly experienced herb users. Product variability not controlled. Not a clinical trial.
[1]
Adulteration of Scutellaria lateriflora with Teucrium species
Multiple investigations into the adulteration of commercial skullcap products with Teucrium canadense (American germander) and/or Teucrium chamaedrys (wall germander), species containing hepatotoxic neo-clerodane diterpenes.
Findings: Studies by Bergeron et al. (2005) and others confirmed that a significant proportion of commercial skullcap products were adulterated with or entirely substituted by Teucrium species. Teucrium spp. contain neo-clerodane diterpenes (teucrin A, teuchamaedryn) that are metabolized by hepatic CYP3A4 to reactive epoxide intermediates causing direct hepatocyte necrosis. Multiple cases of hepatotoxicity attributed to 'skullcap' in the medical literature (e.g., germander-associated hepatitis) are now believed to have resulted from Teucrium adulteration, not from genuine S. lateriflora. TLC, HPLC, and DNA barcoding methods can distinguish the species. The AHP monograph (2009) provides detailed methods for authentication.
Limitations: Not all commercial products were tested. Adulteration rates may vary by market and time period. The degree of ongoing adulteration in the current marketplace is not fully known, though awareness has improved since the early 2000s.
Neuroprotective and anti-inflammatory effects of Scutellaria flavonoids
Review of preclinical evidence for neuroprotective and anti-inflammatory effects of flavonoids found in Scutellaria species, including baicalin, baicalein, wogonin, and scutellarein.
Findings: Scutellaria flavonoids demonstrate neuroprotective effects through multiple mechanisms: GABA-A receptor modulation, antioxidant activity (scavenging of reactive oxygen species), inhibition of inflammatory mediators (NF-kB, COX-2, iNOS, pro-inflammatory cytokines), inhibition of lipoxygenase enzymes (5-LOX, 12-LOX), and modulation of apoptotic pathways in neurons. Baicalein and baicalin showed protective effects against neuronal damage from oxidative stress, ischemia-reperfusion injury, and excitotoxicity in cell culture and animal models. These findings support a scientific basis for the traditional nervine tonic and neuroprotective reputation of Scutellaria species.
Limitations: Most evidence is from S. baicalensis rather than S. lateriflora specifically. In vitro and animal model findings do not directly translate to human clinical outcomes. Doses used in preclinical studies may not reflect achievable human exposures from standard herbal preparations.
Scutellaria lateriflora supplementation and mood in healthy volunteers
A study examining the effects of S. lateriflora supplementation on mood and cognitive performance in healthy volunteers over a 2-week period.
Findings: Brock et al. (2014) demonstrated that S. lateriflora supplementation significantly improved global mood in healthy volunteers compared to placebo. Energy and cognition subscale scores also showed positive trends. The results supported the traditional use of skullcap as a nervine tonic that improves overall nervous system function rather than merely suppressing anxiety symptoms.
Limitations: Healthy volunteers rather than clinical population. Relatively small sample. Short supplementation period. Specific preparation used.
[5]
Preparations & Dosage
Infusion (Tea)
Strength: 1-2 g dried herb per 150-250 mL water
Pour 150-250 mL of boiling water over 1-2 g (approximately 1-2 heaped teaspoons) of dried skullcap aerial parts. Cover and steep for 10-15 minutes. Strain. The infusion has a mildly bitter, slightly grassy flavor that is generally well-tolerated.
One cup (150-250 mL) up to 3 times daily. For sleep: one cup 30-60 minutes before bedtime. For anxiety/nervous tension: 1 cup 3 times daily.
For nervine tonic effect (chronic use): 2-3 times daily consistently. For sleep: single dose before bedtime. For acute anxiety: 1 cup as needed, up to 3 times daily.
For nervine tonic indication, use consistently for 2-8 weeks for optimal effect. May be used long-term. Short-term use for acute anxiety as needed.
Children 6-12 years: half adult dose (0.5-1 g per cup) under professional guidance only. Not recommended for self-medication in children under 12.
Traditional and simple preparation. The British Herbal Pharmacopoeia (1983) recommends an infusion of 1-2 g dried herb three times daily. Many practitioners note that the infusion is effective but consider the tincture (especially fresh plant tincture) to be a more potent preparation. The mild bitterness is generally acceptable; can be combined with Melissa officinalis (lemon balm) or Matricaria recutita (chamomile) for a more pleasant-tasting blend.
Tincture
Strength: Fresh: 1:2, 95% ethanol. Dried: 1:5, 45-60% ethanol
Fresh plant tincture: macerate fresh aerial parts (harvested in flower) in 95% ethanol at a ratio of 1:2 (fresh herb weight to menstruum volume). For dried herb tincture: macerate dried aerial parts in 45-60% ethanol at 1:5 ratio. Macerate for 2-4 weeks, shaking daily. Press and filter. Fresh plant tincture is widely considered the preferred preparation by clinical herbalists.
Fresh plant tincture (1:2, 95%): 2-4 mL up to 3 times daily. Dried herb tincture (1:5, 45%): 1-4 mL up to 3 times daily. BHP recommended dose: 1-2 mL of 1:5 tincture, three times daily. For acute anxiety: 2-4 mL as a single dose, repeated every 2-3 hours if needed.
For tonic effect: 3 times daily consistently. For sleep: 1-2 doses in the evening. For acute anxiety: as needed, up to every 2-3 hours.
For tonic use, 2-8 weeks or longer. For acute use, as needed.
Under professional guidance only. Children 6-12: 0.5-1 mL up to 3 times daily.
The tincture is the most widely used preparation among clinical herbalists, and the fresh plant tincture is strongly preferred by many practitioners. The Eclectic physicians emphasized the superiority of fresh plant preparations (Felter and Lloyd, 1898). Herbalist David Hoffmann specifically recommends the fresh plant tincture. The higher alcohol content in fresh plant tinctures preserves the volatile and labile constituents that may be lost during drying. A well-made fresh plant tincture should have a bright green color and a distinctly bitter, aromatic taste.
capsule-powder
Strength: Dried herb powder: 350-500 mg per capsule. Typical dose 2-4 capsules per serving.
Dried, powdered skullcap aerial parts in gelatin or vegetable capsules. Source only from manufacturers with verified botanical identity to avoid Teucrium adulteration.
1-2 g of dried herb powder up to 3 times daily. BHP: 1-2 g three times daily. AHP monograph supports similar dosing. For standardized extracts: follow manufacturer's guidelines.
For tonic use: 2-3 times daily. For sleep: single dose 30-60 minutes before bedtime.
2-8 weeks for tonic effect; may be used longer-term.
Not recommended for self-medication in children under 12.
Capsules provide convenience and bypass the bitter taste. However, many practitioners consider capsules less effective than tinctures, particularly fresh plant tinctures, for this herb. The Wolfson and Hoffmann (2003) clinical study used a freeze-dried encapsulated preparation (350 mg dose showing significant anxiolytic effect). CRITICAL: Only purchase from reputable suppliers who verify species identity; Teucrium adulteration is a documented concern for encapsulated skullcap products.
Glycerite
Strength: 1:5, 60% glycerin (dried herb) or 1:2, 75% glycerin (fresh herb)
Macerate fresh or dried skullcap aerial parts in vegetable glycerin-water mixture (60-75% glycerin). Glycerites are alcohol-free alternatives suitable for those avoiding alcohol and for children under professional guidance.
3-5 mL up to 3-4 times daily.
For tonic use: 3-4 times daily. For sleep: 1-2 doses in evening.
2-8 weeks for tonic effect.
Under professional guidance. Children 6-12: 1-2 mL up to 3 times daily.
Glycerites provide a palatable, alcohol-free option. The sweet taste of glycerin makes this form acceptable for children (under practitioner supervision). Glycerin is a less efficient solvent than ethanol for some lipophilic constituents, but it extracts flavonoid glycosides (baicalin, scutellarin) adequately. Considered less potent than the fresh plant ethanol tincture by most practitioners.
[6]
combination-formula
Strength: Variable by formula
Skullcap is frequently used in combination with other herbs rather than as a standalone. Common formula patterns: (1) Nervine tonic: skullcap + Avena sativa (milky oats) + Verbena officinalis (vervain); (2) Anxiolytic: skullcap + Passiflora incarnata (passionflower) + Melissa officinalis (lemon balm); (3) Sleep formula: skullcap + Valeriana officinalis (valerian) + Humulus lupulus (hops) + Passiflora incarnata; (4) Tension headache: skullcap + Lavandula angustifolia (lavender) + Matricaria recutita (chamomile).
Varies by formula composition. Skullcap typically constitutes 20-40% of a formula blend.
Per specific formula guidelines.
Per indication and formula design.
Under professional guidance only.
The combination tradition is deeply rooted in Western herbal practice. Skullcap synergizes well with other nervines due to its unique dual tonic-relaxant action. In a nervine formula, skullcap provides the trophorestorative element (restoring nervous system function), while other herbs may contribute stronger sedative (valerian), anxiolytic (passionflower), or adaptogenic (ashwagandha) actions. Many clinical herbalists rarely use skullcap as a single herb, preferring it as a key component of individualized formulas.
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Although allergic reactions to genuine S. lateriflora are extremely rare, patients with known sensitivity should avoid all preparations. Cross-reactivity with other Lamiaceae members (mint, basil, lavender, rosemary) is possible but undocumented.
This caution relates primarily to the adulteration risk with Teucrium species (germander), not to genuine S. lateriflora itself. Cases of hepatotoxicity attributed to 'skullcap' in the medical literature (e.g., MacGregor et al. 1989, reported in the BMJ) are now believed to have been caused by Teucrium contamination rather than by authentic S. lateriflora. Genuine S. lateriflora has not been independently associated with hepatotoxicity when properly authenticated. However, given the historical adulteration problem, patients with pre-existing liver disease should use only thoroughly authenticated products from reputable sources, and liver function monitoring may be prudent with extended use.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Benzodiazepines (diazepam, lorazepam, alprazolam, clonazepam, etc.) (Benzodiazepines / CNS depressants) | moderate | Both skullcap flavonoids (baicalein, wogonin, chrysin) and benzodiazepines modulate GABA-A receptor function at the benzodiazepine binding site. Concurrent use may produce additive CNS depressant effects. |
| Sedative-hypnotic medications (zolpidem, zaleplon, eszopiclone, suvorexant) (Sedative-hypnotics) | moderate | Potential additive CNS depression through overlapping mechanisms affecting GABAergic neurotransmission and sleep architecture. |
| Barbiturates (phenobarbital) and general anesthetics (CNS depressants / Anesthetics) | moderate | Potential additive CNS depression through shared GABAergic mechanisms. |
| Anticonvulsant medications (phenobarbital, phenytoin, carbamazepine, valproic acid) (Anticonvulsants) | theoretical | Skullcap flavonoids have demonstrated anticonvulsant activity in animal models via GABA-A modulation. Theoretical potential for additive effects or altered drug levels (flavonoids may interact with CYP450-mediated drug metabolism). |
| Alcohol (ethanol) (CNS depressants) | minor | Potential additive CNS depression through shared GABAergic mechanisms. |
| Hepatically metabolized drugs (CYP3A4, CYP1A2 substrates) (Various) | theoretical | In vitro studies suggest that baicalein and other Scutellaria flavonoids can modulate CYP3A4 and CYP1A2 activity. However, the concentrations required for significant enzyme inhibition in vitro may not be achieved at standard oral doses in humans. |
Pregnancy & Lactation
Pregnancy
insufficient data
Lactation
insufficient data
PREGNANCY: Insufficient data to establish safety during pregnancy. The Eclectic physicians did not specifically contraindicate skullcap in pregnancy and occasionally used it for gestational nervousness, but modern safety data is lacking. The emmenagogue use by Cherokee (promoting menses) suggests potential uterine activity, warranting caution. AHPA Botanical Safety Handbook (2nd edition) does not assign a pregnancy restriction (Safety Class 1), but notes that safety in pregnancy has not been established. Most modern authorities recommend caution or avoidance during pregnancy due to lack of safety data rather than evidence of harm. LACTATION: Insufficient data. Not known whether constituents pass into breast milk. Use during breastfeeding should be under professional guidance only.
Adverse Effects
References
Monograph Sources
- [1] Upton R, Graff A, Jolliffe G, Langer R, Williamson E (eds.). American Herbal Pharmacopoeia and Therapeutic Compendium: Skullcap — Scutellaria lateriflora L. Standards of Analysis, Quality Control, and Therapeutics. American Herbal Pharmacopoeia, Scotts Valley, CA (2009)
- [2] British Herbal Medicine Association. British Herbal Pharmacopoeia: Scutellaria lateriflora. British Herbal Medicine Association, Bournemouth (1983) : 200-201
- [3] Gardner Z, McGuffin M (eds.). American Herbal Products Association's Botanical Safety Handbook, Second Edition. CRC Press, Boca Raton (2013) : 791-793
Clinical Studies
- [4] Wolfson P, Hoffmann DL. An investigation into the efficacy of Scutellaria lateriflora in healthy volunteers. Altern Ther Health Med (2003) ; 9 : 74-78 . PMID: 12652885
- [5] Brock C, Whitehouse J, Tewfik I, Towell T. American skullcap (Scutellaria lateriflora): a randomised, double-blind placebo-controlled crossover study of its effects on mood in healthy volunteers. Phytother Res (2014) ; 28 : 692-698 . DOI: 10.1002/ptr.5044 . PMID: 23878109
Traditional Texts
- [6] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press, Rochester, VT (2003) : 586-587
- [7] Mills S, Bone K. Principles and Practice of Phytotherapy: Modern Herbal Medicine. Churchill Livingstone, Edinburgh (2000) : 527-531
- [8] Felter HW, Lloyd JU. King's American Dispensatory (18th edition, 3rd revision): Scutellaria. Ohio Valley Company, Cincinnati (1898)
- [9] Ellingwood F. American Materia Medica, Therapeutics and Pharmacognosy: Scutellaria. Ellingwood's Therapeutist, Chicago (1919)
- [10] Moerman DE. Native American Ethnobotany. Timber Press, Portland, OR (1998)
Pharmacopeias & Reviews
- [11] Awad R, Arnason JT, Trudeau V, Bergeron C, Budzinski JW, Foster BC, Merali Z. Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties. Phytomedicine (2003) ; 10 : 640-649 . DOI: 10.1078/0944-7113-00374 . PMID: 14692723
- [12] Bergeron C, Gafner S, Clausen E, Bhatt DJ. Comparison of the chemical composition of extracts from Scutellaria lateriflora using LC-DAD-MS and LC-DAD-UV analyses. J Agric Food Chem (2005) ; 53 : 943-948
- [13] Gafner S. Adulteration of Scutellaria lateriflora (Skullcap). Botanical Adulterants Bulletin, ABC-AHP-NCNPR Botanical Adulterants Prevention Program (2015)
Last updated: 2026-03-01 | Status: published
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.